BRAIN Biotech AG reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported sales was EUR 12.73 million compared to EUR 13.69 million a year ago. Revenue was EUR 13.08 million compared to EUR 13.5 million a year ago.

Net loss was EUR 2.65 million compared to EUR 2.53 million a year ago. Basic loss per share from continuing operations was EUR 0.12 compared to EUR 0.12 a year ago. Diluted loss per share from continuing operations was EUR 0.12 compared to EUR 0.12 a year ago.